Aloso, Marielle A.
HRN: 27-17-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/23/2025
CEFUROXIME 500MG (TAB)
05/23/2025
05/29/2025
PO
500mg
BID
RMLE; Thinly MSAF
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes